Measured publishes the widest catalogue we reviewed — fourteen-plus options — and, more usefully, labels every line twice: whether insurance is required, and whether medication is included.
Compounded semaglutide is $119 a month with medication included and no insurance required, on top of a membership from $49. That is about $168 all-in, which places it above CoreAge Rx at $79 and Mochi at $139, and below Eden at $198.
What separates Measured is what the membership funds. Most providers at this price point give you a prescriber and a messaging inbox. Measured staffs obesity-trained providers alongside registered dietitians and care coordinators, with unlimited messaging to all three.
The microdose option
Measured publishes a GLP-1 microdose plan at $79 a month with medication included — weekly lower-dose semaglutide or tirzepatide. It is the cheapest line in its catalogue and needs care in interpretation.
The branded gap
Measured lists Wegovy, Ozempic, Zepbound, Mounjaro and the Wegovy Pill "from $49/mo" — but that $49 is the membership, with medication paid separately at a price the company does not publish anywhere.
So the compounded half of the grid is comparable across providers and the branded half is not. If you are heading for Wegovy or Zepbound, you cannot price Measured against Eden or Mochi from published information. That is a real gap in an otherwise unusually well-labelled catalogue.
Your muscle-protection numbers
Weight lost on a GLP-1 is not all fat. Protein intake and resistance training are the two levers with the best evidence behind them. Set your weight to see the targets.
Daily protein target
120–200 g
Roughly 30 g at each of four eating occasions gets you to the bottom of that range.
Resistance training
2–3 ×/week
Full-body sessions covering legs, push and pull. Loaded movement is the signal that tells your body to keep the muscle.
General nutrition and activity information, not medical advice. Protein targets can be inappropriate in kidney disease and some other conditions — check with your clinician before changing your intake.
What compounded semaglutide actually is
Semaglutide is the active ingredient in Ozempic and Wegovy, both FDA-approved products from Novo Nordisk. A compounded version is prepared by a pharmacy rather than manufactured by Novo Nordisk, and it is not an FDA-approved product. FDA has not evaluated it for safety, effectiveness or quality.
That distinction is the single most important thing to understand before buying. The efficacy data you have read about — the 15% average body-weight reduction, the cardiovascular outcomes — comes from trials of the branded product. Those results are routinely used to sell compounded versions that were never in the trials.
Dosing typically starts at 0.25 mg weekly and escalates over several months toward a maintenance dose, which is why dose-dependent pricing matters so much: a plan that looks cheap at the starting dose can cost several times more by the time you reach a therapeutic one.
The common side effects are gastrointestinal — nausea, vomiting, diarrhoea, constipation — and are usually worst in the days after a dose increase. They are the main reason people stop. Slower titration and adequate fibre and fluid intake are the standard mitigations.
Before you buy from anyone
- Get the total monthly cost in writing — medication plus any membership, not the headline figure.
- Ask whether the price changes as your dose increases. This is where most of the money is lost.
- Ask which pharmacy compounds it, and whether it is a 503A or 503B facility.
- Confirm what happens if you stop after one month, and whether there is an auto-rebill.
- Ask whether a refund is available if a provider declines to prescribe.
- Tell the prescriber every medication and supplement you take, including anything bought online.